Immobilization-dependent bone collagen breakdown appears to increase with time: Evidence for a lack of a new bone equilibrium in response to reduced load during prolonged bed rest

被引:25
作者
Fiore, CE
Pennisi, P
Ciffo, F
Scebba, C
Amico, A
Di Fazzio, S
机构
[1] Univ Catania, Dept Internal Med, Catania, Italy
[2] Santo Pietro Hosp, Dept Geriatr Med & Extended Care, Caltagirone, Italy
关键词
immobilization bone loss; type I collagen; bone resorption;
D O I
10.1055/s-2007-978693
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study was to evaluate the effect of prolonged immobilization on bone, in order to investigate how skeletal turnover adapts to bed rest. We examined indices of bone formation and bone resorption in the serum and urine of fifty-four patients (26 males and 28 females) immobilized after an episode of paralytic stroke. The length of immobilization ranged from 30 to 180 days. A significant, time-dependent increase in markers of resorption - urinary pyridinoline (Pyr) and deoxypyridinoline (D-Pyr), serum Type I collagen cross-linked C-telopeptide (ICTP)- was observed in immobilized patients, as compared to free-living healthy subjects. The positive correlation between resorption markers increase and the length of immobilization suggests that the rate of bone resorption did not decrease with time. On the other hand, the levels of markers of bone formation - bone-specific alkaline phosphatase (B-ALP), and the carboxyl-terminal propeptide of Type I procollagen (PICP) - remained within the normal range in all patients, regardless the length of immobilization. Our results would indicate an uncoupling between bone formation and bone resorption during bed rest, and suggest that the bone collagen breakdown was not a self-limiting process in immobilized patients, and that a new equilibrium or "steady state" in response to the reduced load was not reached in the skeleton.
引用
收藏
页码:31 / 36
页数:6
相关论文
共 35 条
  • [1] ARNAUD SB, 1992, AVIAT SPACE ENVIR MD, V63, P14
  • [2] DALLOLIO G, 1993, EUROP J LAB MED, V1, P147
  • [3] DELMAS PD, 1990, ENDOCRIN METAB CLIN, V19, P1
  • [4] DONALDSON C L, 1970, Metabolism Clinical and Experimental, V19, P1071, DOI 10.1016/0026-0495(70)90032-6
  • [5] CONCURRENT ASSAYS OF CIRCULATING BONE GLA-PROTEIN AND BONE ALKALINE-PHOSPHATASE - EFFECTS OF SEX, AGE, AND METABOLIC BONE-DISEASE
    DUDA, RJ
    OBRIEN, JF
    KATZMANN, JA
    PETERSON, JM
    MANN, KG
    RIGGS, BL
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 66 (05) : 951 - 957
  • [6] ERIKSEN EF, 1993, J BONE MINER RES, V8, P127
  • [7] COMPARISON OF NEW BIOCHEMICAL MARKERS OF BONE TURNOVER IN LATE POSTMENOPAUSAL OSTEOPOROTIC WOMEN IN RESPONSE TO ALENDRONATE TREATMENT
    GARNERO, P
    SHIH, WCJ
    GINEYTS, E
    KARPF, DB
    DELMAS, PD
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (06) : 1693 - 1700
  • [8] GARNERO P, 1995, J BONE MINER RES, V10, P641
  • [9] ASSESSMENT OF THE SERUM LEVELS OF BONE ALKALINE-PHOSPHATASE WITH A NEW IMMUNORADIOMETRIC ASSAY IN PATIENTS WITH METABOLIC BONE-DISEASE
    GARNERO, P
    DELMAS, PD
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (04) : 1046 - 1053
  • [10] Strain gradients correlate with sites of periosteal bone formation
    Gross, TS
    Edwards, JL
    McLeod, KJ
    Rubin, CT
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 (06) : 982 - 988